SCHEMBL10845552

SCHEMBL10845552

CCc1nnc2c(Cl)nc3ccc(Cl)cc3n12

nearest known ligand 0.76

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CUL4A Q13619 1/20 0.50
PDE2A O00408 1/20 0.47
PDE10A Q9Y233 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10845391 0.89 PDE2A (0.47) PDE2A
SCHEMBL10849092 0.86
SCHEMBL10845502 0.86 TP53 (0.47) PDE2APDE10A
SCHEMBL10847133 0.84 TP53 (0.46) PDE2APDE10A
SCHEMBL10844397 0.83
SCHEMBL7340895 0.82 HTR2C (0.66)
SCHEMBL10845609 0.82 GRIN2D (0.42)
SCHEMBL10844601 0.81
SCHEMBL10846312 0.81 CUL4A (0.54) CUL4APDE2APDE10A
SCHEMBL10848258 0.79 TP53 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4623725-A [1,2,4]Triazolo[4,3-a]quinoxaline-4-amine derivatives PFIZER INC. (US) 1986-11-18 US disclosed
EP-0107455-B1 TRIAZOLOQUINOXALINES AS ANTIDEPRESSANTS AND ANTIFATIGUE AGENTS PFIZER INC. (US) 1986-07-09 EP disclosed
US-4547501-A Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents PFIZER INC. (US) 1985-10-15 US disclosed
US-4495187-A Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents PFIZER INC. (US) 1985-01-22 US disclosed
EP-0107455-A1 Triazoloquinoxalines as antidepressants and antifatigue agents PFIZER INC. (US) 1984-05-02 EP disclosed